|Articles|February 25, 2016

Clostridium difficile Infection at Local Elementary School

Author(s)Sarah Anwar

The student was diagnosed with Clostridium difficile infection (CDI) on February 7, 2016 at Liberty Elementary School of Broken Arrow, Oklahoma.

The student was diagnosed with Clostridium difficile infection (CDI) on February 7, 2016 at Liberty Elementary School of Broken Arrow, Oklahoma. The school issued a statement addressing the matter.

CDI has received a lot of attention recently since the Centers for Disease Control and Prevention (CDC) has branded the superbug an urgent threat, and has advised individuals to take the necessary precautions to prevent infection.

CDI is highly contagious through contact with surfaces, objects, or body parts contaminated with human feces. An individual can contract the infection by unknowingly ingesting the bacteria. The CDC states that although some individuals may carry a CDI germ, they may remain asymptomatic due to the beneficial bacteria of the microbiome in their guts which cause CDI bacteria to become dormant. With the use of long term antibiotics, however, these germ-fighting-bacteria die off, leaving the host susceptible to infection.

Symptoms associated with CDI include:

  • Watery diarrhea (at least three times a day for two or more days)
  • Fever
  • Loss of appetite
  • Nausea
  • Abdominal pain or tenderness

It is crucial that individuals experiencing these symptoms seek professional diagnosis and treatment.

Working in conjunction with the health department of Oklahoma, executives at Liberty Elementary School took cautionary steps to guarantee the school is now infection free. The CDC advises that to prevent an outbreak where an infected patient resides, it is vital to not only disinfect all surfaces with hypochlorite-based cleaners, but to also disinfect all devices used by the individual. Prior to the school’s reopening on Monday, February 8, all restrooms, common areas, and the classroom previously inhabited by the infected student, were sterilized. The student will not be returning to school until he/she is symptom-free.

The CDC advises that after coming in contact with CDI patients, individuals wash their hands thoroughly with soap and water (even with the use of gloves), since most alcohol-based hand rubs do not effectively kill off C. diff spores. As a result, Liberty Elementary warned all parents to be on the lookout for symptoms of CDI in their own children, further advising them to keep their child home if they are infected. In addition, the school instructed parents to review proper handwashing methods with their children, as an extra precaution to prevent future illnesses.

Liberty Elementary school did not release any indication of the severity of the student’s case. The school assured the public that any risk of initial infection was very low, however, necessary steps were taken to prevent future outbreaks.


Related to this article

LMN-201 Reduces C difficile Recurrence
In the phase 2 RePreve trial, Lumen Bioscience’s investigational oral biologic LMN-201 plus standard antibiotics achieved global cure in 83.3% of patients with C difficile infection vs 36.4% with placebo, and cut recurrence sixfold (9.1% vs 55.6%) with no drug-related serious adverse events.
Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.